Home › Mild Cognitive Impairment › Minnesota › Rochester
Mild Cognitive Impairment clinical trials in Rochester, MN
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Mayo Clinic in Rochester, Minnesota, Rochester
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecruitingObservational study
- Mayo Clinic, Rochester
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Mayo Clinic, Rochester
Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
RecruitingObservational study
- Mayo Clinic, Rochester
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY24 studies
- Boston, MA21 studies
- Chicago, IL17 studies
- Baltimore, MD16 studies
- Los Angeles, CA12 studies
- Philadelphia, PA11 studies
- Miami, FL11 studies
- Birmingham, AL11 studies
- Atlanta, GA10 studies
- San Francisco, CA10 studies
- Houston, TX10 studies
- St. Louis, MO9 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Multiple Myeloma24 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Pancreatic Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.